Curative Biotechnology Stock Forward View - Simple Moving Average
| CUBT Stock | USD 0.01 0.0007 10.14% |
Curative Stock outlook is based on your current time horizon.
At this time, the RSI of Curative Biotechnology's share price is approaching 48 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Curative Biotechnology, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Using Curative Biotechnology hype-based prediction, you can estimate the value of Curative Biotechnology from the perspective of Curative Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Curative Biotechnology on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0006 and the sum of the absolute errors of 0.04. Curative Biotechnology after-hype prediction price | USD 0.007827 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Curative Biotechnology to cross-verify your projections. Curative Biotechnology Additional Predictive Modules
Most predictive techniques to examine Curative price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Curative using various technical indicators. When you analyze Curative charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Curative Biotechnology Simple Moving Average Price Forecast For the 1st of February
Given 90 days horizon, the Simple Moving Average forecasted value of Curative Biotechnology on the next trading day is expected to be 0.01 with a mean absolute deviation of 0.0006, mean absolute percentage error of 0.00000072, and the sum of the absolute errors of 0.04.Please note that although there have been many attempts to predict Curative Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Curative Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Curative Biotechnology Stock Forecast Pattern
| Backtest Curative Biotechnology | Curative Biotechnology Price Prediction | Buy or Sell Advice |
Curative Biotechnology Forecasted Value
In the context of forecasting Curative Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Curative Biotechnology's downside and upside margins for the forecasting period are 0.000062 and 12.02, respectively. We have considered Curative Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Curative Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Curative Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 102.1328 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 6.0E-4 |
| MAPE | Mean absolute percentage error | 0.0947 |
| SAE | Sum of the absolute errors | 0.0378 |
Predictive Modules for Curative Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Curative Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Curative Biotechnology After-Hype Price Density Analysis
As far as predicting the price of Curative Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Curative Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Curative Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Curative Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Curative Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Curative Biotechnology's historical news coverage. Curative Biotechnology's after-hype downside and upside margins for the prediction period are 0.00 and 12.02, respectively. We have considered Curative Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Curative Biotechnology is out of control at this time. Analysis and calculation of next after-hype price of Curative Biotechnology is based on 3 months time horizon.
Curative Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Curative Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Curative Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Curative Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.62 | 12.01 | 0.00 | 0.00 | 3 Events / Month | 3 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.01 | 0.01 | 26.24 |
|
Curative Biotechnology Hype Timeline
Curative Biotechnology is currently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Curative is forecasted to increase in value after the next headline, with the price projected to jump to 0.007827 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is forecasted to be 26.24%, whereas the daily expected return is currently at 0.62%. The volatility of related hype on Curative Biotechnology is about 4003333.33%, with the expected price after the next announcement by competition of 0.01. Curative Biotechnology currently holds 1.37 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Historical Fundamental Analysis of Curative Biotechnology to cross-verify your projections.Curative Biotechnology Related Hype Analysis
Having access to credible news sources related to Curative Biotechnology's direct competition is more important than ever and may enhance your ability to predict Curative Biotechnology's future price movements. Getting to know how Curative Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Curative Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QNNTF | Quantum Genomics Socit | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TXTM | Protext Mobility | (0.0006) | 12 per month | 4.88 | 0.12 | 16.13 | (8.33) | 32.26 | |
| CHMMF | Chimeric Therapeutics Limited | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BETRF | BetterLife Pharma | (0.0006) | 3 per month | 8.46 | 0.01 | 22.58 | (16.33) | 52.18 | |
| THER | Therasense | (0.0006) | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CPMV | Mosaic Immunoengineering | (0.0006) | 9 per month | 10.04 | 0.09 | 51.52 | (22.00) | 106.28 | |
| BVAXF | Biovaxys Technology Corp | (0.0006) | 6 per month | 0.00 | (0.01) | 12.50 | (10.53) | 42.22 | |
| GLWLF | Glow Lifetech Corp | 0.00 | 0 per month | 0.00 | 0.04 | 5.25 | (2.70) | 27.60 | |
| FAMDF | Futura Medical plc | 0.00 | 0 per month | 26.18 | 0.21 | 127.27 | (50.00) | 480.00 | |
| NSHSF | Nanosphere Health Sciences | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 216.93 |
Other Forecasting Options for Curative Biotechnology
For every potential investor in Curative, whether a beginner or expert, Curative Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Curative Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Curative. Basic forecasting techniques help filter out the noise by identifying Curative Biotechnology's price trends.Curative Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Curative Biotechnology stock to make a market-neutral strategy. Peer analysis of Curative Biotechnology could also be used in its relative valuation, which is a method of valuing Curative Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Curative Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how Curative Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Curative Biotechnology shares will generate the highest return on investment. By undertsting and applying Curative Biotechnology stock market strength indicators, traders can identify Curative Biotechnology entry and exit signals to maximize returns.
| Accumulation Distribution | 0.1 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.9 | |||
| Day Median Price | 0.0066 | |||
| Day Typical Price | 0.0064 | |||
| Market Facilitation Index | 7.0E-4 | |||
| Price Action Indicator | (0.0007) | |||
| Period Momentum Indicator | (0.0007) | |||
| Relative Strength Index | 48.62 |
Curative Biotechnology Risk Indicators
The analysis of Curative Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Curative Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting curative stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.33 | |||
| Semi Deviation | 10.93 | |||
| Standard Deviation | 13.54 | |||
| Variance | 183.46 | |||
| Downside Variance | 178.12 | |||
| Semi Variance | 119.48 | |||
| Expected Short fall | (11.85) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Curative Biotechnology
The number of cover stories for Curative Biotechnology depends on current market conditions and Curative Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Curative Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Curative Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Curative Biotechnology Short Properties
Curative Biotechnology's future price predictability will typically decrease when Curative Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Curative Biotechnology often depends not only on the future outlook of the potential Curative Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Curative Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 907.9 M | |
| Cash And Short Term Investments | 19.5 K |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.